Researcher.Life Logo

Diabetes, Obesity and Metabolism : Impact Factor & More

eISSN: 1463-1326pISSN: 1462-8902

Key Metrics

CiteScore
12.1
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.88 5-Year SI
SJR
Q1Endocrinology
SNIP
1.51
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Diabetes, Obesity and Metabolism

Diabetes, Obesity and Metabolism Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1999
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Diabetes, Obesity and Metabolism ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Diabetes, Obesity and Metabolism

Title not available
  • 1 Dec 2025
  • Diabetes, Obesity and Metabolism
Safety and efficacy of the therapy with CD4 + CD25highCD127-T regulatory cells: When paediatric patient becomes adult.
  • 26 Nov 2025
  • Diabetes, obesity & metabolism
Obicetrapib for dyslipidemia with or without cardiovascular risk: A GRADE-assessed meta-analysis of randomized trials with trial sequential evidence.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Correlation between diabetes complications severity index and actual complication severity and diabetic medication in Japanese patients with type 2 diabetes mellitus.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Title not available
  • 1 Dec 2025
  • Diabetes, Obesity and Metabolism
Safety and efficacy of the therapy with CD4 + CD25highCD127-T regulatory cells: When paediatric patient becomes adult.
  • 26 Nov 2025
  • Diabetes, obesity & metabolism
Obicetrapib for dyslipidemia with or without cardiovascular risk: A GRADE-assessed meta-analysis of randomized trials with trial sequential evidence.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Assessment of thyroid cancer risk associated with glucagon-like peptide 1 receptor agonist use.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Correlation between diabetes complications severity index and actual complication severity and diabetic medication in Japanese patients with type 2 diabetes mellitus.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism
Sensory network dysregulation in type 2 diabetes: Linking olfactory, visual, and cognitive function.
  • 25 Nov 2025
  • Diabetes, obesity & metabolism

FAQs on Diabetes, Obesity and Metabolism